Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE Cell-Therapy Platform Toward First-in-Human Study
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study…
UltraLuxe Singapore 2025 Showcases The Collectable And Investible In Niche Luxury Through Immersive And Social Experiences
SINGAPORE, Aug. 20, 2025 /PRNewswire/ -- From jewellery and fashion to art, wellness,…
